Synthroid, scientifically known as thyroid hormone, is a prescription medication classified as a synthetic form of the hormone thyroid. It is primarily used to treat hypothyroidism by replacing or replacing thyroid hormones in individuals who are hypothyroid due to an imbalanced thyroid metabolism. It is also commonly used in combination with other thyroid hormone therapies to treat hypothyroidism in patients with other medical conditions such as rheumatoid arthritis or ankylosing spondylitis.
The global Synthroid market is anticipated to experience significant growth over the coming years. As of 2023, the global Synthroid market size was valued at approximately $20.6B USD and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.2% from 2024 to 2030[1-3].
The Synthroid market is driven by several key factors:
The Synthroid market is expected to witness steady growth driven by increasing prevalence of thyroid symptoms, advancements in pharmaceutical formulations, and advancements in healthcare. The market is anticipated to experience steady growth due to ongoing innovations in the treatment of hypothyroidism, ample supply chain and continuous expansion of healthcare sectors[1-3].
The cost of Synthroid can remain a key factor in determining the market size. The cost of Synthroid can differ based on the dosage, formulation, and insurance coverage. The price of Synthroid can also be influenced by the type of insurance agreement reached during the acquisition and marketing of Synthroid. It is essential to understand the cost-saving opportunities offered by Synthroid to minimize the financial burden on patients and healthcare systems[3].
The future outlook for the Synthroid market is positive with the introduction of generic versions of the drug, advancements in pharmaceutical formulations, and increased awareness about thyroid disorders. However, the market outlook for 2023 will continue to be influenced by ongoing innovations in Synthroid, innovations in insurance policies, and strategic partnerships.
Global Market Size & GrowthThe Synthroid market is expected to grow significantly in the future, reaching $20.6B USD in 2024 and is projected to grow at a CAGR of 6.2% from 2024 to 2030[1-3].
The global Synthroid market is driven by various factors:
Synthroid (Levothyroxine Sodium) is an anti-paranoid medication, used to treat the symptoms of hypothyroidism.
Synthroid is commonly used to treat hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormones. This helps to restore the thyroid hormone balance needed for the thyroid gland to function properly.
Synthroid is an approved medication used to treat hypothyroidism, an underactive thyroid gland, in adults. It is used to treat symptoms of hypothyroidism in adult patients.
Synthroid works by stimulating the production of the thyroid hormone thyroxine (T4) and triiodothyronine (T3).
It is typically prescribed in the following ways:
Medical treatment:The medication must be taken as prescribed by a healthcare provider, typically a physician with a thyroid medicine office.
Laboratory testing:Synthroid is used to determine the amount of thyroid hormone that is produced by the body.
Pharmacological treatment:It can be used to treat hypothyroidism, especially in the case of patients with pre-existing conditions. For example, it can be used to treat hypothyroidism in patients with an enlarged thyroid gland.
Synthroid is also prescribed as a thyroid hormone replacement therapy, but it is typically used as an adjunct to an antidiabetic (e.g. sulfonylureas or insulin) or as a preventative measure to prevent hypothyroidism. This is when a medication is prescribed to control symptoms.
Synthroid is an anti-hyperthyroidism medication. It contains T4 and T3, which are hormones that cause the body to produce too much of the thyroid hormone thyroxine (T4). This increases the amount of the thyroid hormone T4 needed to make thyroid hormone.
The medication begins working within 1 to 3 days of starting treatment. The goal is to see the patient’s thyroid gland return to its normal level within 2-3 days, without further side effects.
If you need to take Synthroid for more than a week, your healthcare provider may recommend a different treatment for you or to see if you will need the medication for another few days.
The dosage of Synthroid for treating hypothyroidism depends on the condition being treated and the patient’s response to the medication. The typical starting dose for adults is 25 mcg, which is the usual dosage.
The dosage of Synthroid for treating hypothyroidism ranges from 25 to 300 mcg every 4 weeks.
Synthroid may cause some side effects. These can include:
Synthroid, commonly known by its trade name Levoxyl®, is a medication prescribed for hypothyroidism. It works by supplementing thyroid hormones in the body, helping to regulate metabolism, mood, and other functions.
The global Synthroid market is significant and growing. As of 2023, the market size was valued at USD 8.6 billion and is projected to reach USD 13.9 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 6.8% from 2024 to 2031[1].
North America dominates the market, accounting for more than 40% of the revenue. The US entry into North America in 2023 will likely boost the market, though. A representative with North Carolina was quoted in a 2024 study in pharma first, which suggested a CAGR of 7.6%. In25ib, North Carolina was associated with a CAGR of 8.2% and North Dakota with a CAGR of 4.2%.
Europe is expected to grow at a CAGR of 4.2% during the 2023 to 2031 period. However, the market is still in aSources of growthlm with a CAGR of 6.8% regionally, while dosage form sales are at their baseline. North America is the hardest-to-steady barrier to entry, with a CAGR of 6.6% globally and only 0.2% in the US. US sales were up 3.8% for North America in 2024 and are up 5.0% for the US in 2025[1].
North AmericaATop is expected to dominate the North American market, driven by a higher demand for thyroid hormone replacement and improved healthcare. The market is driven by several key factors:
Regional Analysis: North America is expected to dominate the market due to a higher healthcare spending goal, a higher demand for levothyroxine and increased awareness about its benefits, and improved healthcare systems. North America is also a leading region, driven by a higher incidence of cardiovascular disease and a strong demand for hormone replacement therapy[1].
Pharmacy Analysis: The purchase of pharmacy benefit drugs is a significant factor in the market, with Medicare paying out-of-pocket as a portion of the cost. Patients pay $25 for a 90-day supply of Prescriptionona®, which is equivalent to $20 for 30 tablets of Synthroid. The savings are significant and can be significant for patients with limited access to Medicare Part D or for those with ongoing drug costs[1].
Healthcare Infrastructure: In regions like the US, in which the economy is weak, healthcare systems are improving, hospitality rising, and drug costs are rising. North America is expected to continue its dominance due to growing healthcare access and improved infrastructure[1].
This region is also expected to see the highest growth driven by improving healthcare access and improving the delivery system. The Asia-Pacific is the fastest-growing region in 2024, driven by a lack of skilled labour and improved economic conditions. The market is also growing due to improving healthcare infrastructure and improving medical facilities[1].
Europe is expected to be the fastest-growing market in 2024, driven by a higher demand for thyroid hormone replacement and improved healthcare systems. The market is also growing due to improving healthcare infrastructure. North America is the hardest-to-steady barrier to entry, 0.2% of the market, 0.2% in US sales, but 0.2% in Japan[1].
The cost for Synthroid can vary based on dosage form, cost, and form. The average cost for a 30-day supply of 50mcg cost $74.05 for 30 tablets, compared to $64.60 for a 100-day supply of 50mcg. Similarly, Prescriptionona 50mcg costs $8.27 for a 90-day supply of Synthroid 30 tablets, with 90-day supplies of 50mcg versus $8.27 for a 100-day supply[2].
Thyroid hormone replacement (THR) is primarily used for the management of hypothyroidism (underactive thyroid) in adults and in adolescents (juvenile myeloma). Thyroid hormones play a vital role in regulating metabolism and lipid metabolism.Thyroid hormones are synthetic messengers with identical physiological effects as complex messengers. They regulate various bodily processes, such as bowel motility, bone metabolism, nervous system function and energy balance, and as a result, managing insulin resistance, bone metabolism problems or metabolic disorders in adults and in adolescents (juvenile myeloma).
Euthyroxal:Management of hypothyroidism:Thyroidide injections provide short-term relief of hypothyroid symptoms and are particularly useful in patients with very low thyroid hormone levels. Long-term therapy may be required to improve thyroid hormone levels, as the dosage may be adjusted.
Metformin:Management of acute and post-traumatic thyroid antibodies (hunting disorders).
Contraindications:
Thyroidide therapy may not be needed if managing thyroid disorders, especially if managing hypothyroid symptoms. Negative effect on other medications may be observed. Precise definition of patients who meet these criteria is essential.
Generic Synthroid is a brand name for the synthetic thyroid hormone levothyroxine, which is an important hormone in bodybuilding, exercise, and hair loss. It is sometimes sold under other names such as Tylenol, Levothroid, and Risperdal. This medication is also used to treat. It comes as a tablet to take by mouth, but the manufacturer of this product does not currently manufacture the tablet. The generic name for this medication is levothyroxine sodium, which is available as a tablet. This medication is manufactured by various pharmaceutical companies, including GlaxoSmithKline, Mylan, and Pfizer. It is also used to treat hypothyroidism. The manufacturer of this medication does not currently manufacture the tablet. However, it is available as a generic equivalent, such as Synthroid.
Generic Synthroid can be obtained from various online sources, such as,, and. These sources of generic levothyroxine are also available, including Synthroid Online Pharmacy and Synthroid Online Prescription Services. However, the manufacturer of this medication does not currently manufacture the tablet.
This medication is available as a brand-name medication, as well as a generic equivalent, such as Synthroid.
Stade de France Pharmacy